Skip to content

Effects of periodontal therapy in individuals with obesity

Effects of non-surgical periodontal therapy in the treatment of Periodontitis in individuals with obesity

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4c3pdbz
Enrollment
Unknown
Registered
2024-11-08
Start date
2024-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Interventions

This is a non-randomized clinical study. A total of 46 individuals who meet the eligibility criteria will be divided into two experimental groups according to Body Mass Index (BMI) and waist circumfe
ii) obese group (n=23), BMI greater than or equal to 30 kg/m2 and WC greater than 90 cm for men and greater than 80 cm for women. Initially, the patients will undergo anamnesis, receive prophylaxis an
E06.721.189.350

Sponsors

Universidade de São Paulo
Lead Sponsor
Faculdade de Odontologia de Ribeirão Preto da Universidade de São Paulo
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Volunteers of both genders; presence of at least 15 natural teeth excluding third molars and teeth with indication for extraction; diagnosis of generalized periodontitis stage III grade A or B; 30% of teeth with probing depth and clinical attachment level greater than or equal to 5mm

Exclusion criteria

Exclusion criteria: Body Mass Index (BMI) between 25 kg/m2 and 29.9 kg/m2; presence of systemic conditions that may affect the progression of PE or the response to its treatment; long-term administration of anti-inflammatory or immunosuppressive medication; periodontal treatment and/or use of antimicrobials in the last 6 months; continuous use of mouthwashes containing antimicrobial agents in the last 6 months; need for prophylactic antibiotic therapy for routine dental procedures; chronic gastrointestinal diseases; extensive prosthetic rehabilitations; tobacco use currently or in the last 5 years; pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Evaluate the differences in Clinical Attachment Level between the experimental groups at the beginning and end of the study

Secondary

MeasureTime frame
Evaluate the differences in probing depth between the experimental groups at the beginning and end of the study

Countries

Brazil

Contacts

Public ContactFlávia Aparecida Furlaneto

Universidade de São Paulo

flafurlaneto@hotmail.com+55 (16) 3602-4140

Outcome results

None listed

Source: REBEC (via WHO ICTRP)